Abstract:BACKGROUND:Prostate cancer (PCa) is the second leading cause of tumor-related mortality in men. Metastasis from advanced tumors is the primary cause of death among patients. Identifying novel and effective biomarkers is essential for understanding the mechanisms of metastasis in PCa patients and developing successful interventions. METHODS:Using the GSE8511 and GSE27616 data sets, 21 metastasis-related genes were identified through the weighted gene co-expression network analysis (WGCNA) method. Subsequent functional analysis of these genes was conducted on the gene set cancer analysis (GSCA) website. Cluster analysis was utilized to explore the relationship between these genes, immune infiltration in PCa, and the efficacy of targeted drug IC50 scores. Machine learning algorithms were then employed to construct diagnostic and prognostic models, assessing their predictive accuracy. Additionally, multivariate COX regression analysis highlighted the significant role of POLD1 and examined its association with DNA methylation. Finally, molecular docking and immunohistochemistry experiments were carried out to assess the binding affinity of POLD1 to PCa drugs and its impact on PCa prognosis. RESULTS:The study identified 21 metastasis-related genes using the WGCNA method, which were found to be associated with DNA damage, hormone AR activation, and inhibition of the RTK pathway. Cluster analysis confirmed a significant correlation between these genes and PCa metastasis, particularly in the context of immunotherapy and targeted therapy drugs. A diagnostic model combining multiple machine learning algorithms showed strong predictive capabilities for PCa diagnosis, while a transfer model using the LASSO algorithm also yielded promising results. POLD1 emerged as a key prognostic gene among the metastatic genes, showing associations with DNA methylation. Molecular docking experiments supported its high affinity with PCa-targeted drugs. Immunohistochemistry experiments further validated that increased POLD1 expression is linked to poor prognosis in PCa patients. CONCLUSIONS:The developed diagnostic and metastasis models provide substantial value for patients with prostate cancer. The discovery of POLD1 as a novel biomarker related to prostate cancer metastasis offers a promising avenue for enhancing treatment of prostate cancer metastasis.

Identification of Genes Involved in Breast Cancer Metastasis by Integrating Protein-Protein Interaction Information with Expression Data.

Delineating the Underlying Molecular Mechanisms and Key Genes Involved in Metastasis of Colorectal Cancer Via Bioinformatics Analysis

Identification of Novel Breast Cancer Genes Based on Gene Expression Profiles and PPI Data

Identification of Breast Cancer Metastasis Markers from Gene Expression Profiles Using Machine Learning Approaches

Identifying Protein Interaction Subnetworks by a Bagging Markov Random Field-Based Method.

Identifying Breast Cancer-Related Genes Based on a Novel Computational Framework Involving KEGG Pathways and PPI Network Modularity

Identification of Genes Associated with Breast Cancer Metastasis to Bone on A Protein-Protein Interaction Network with A Shortest Path Algorithm

Identification of Novel Cancer-Related Genes with a Prognostic Role Using Gene Expression and Protein-Protein Interaction Network Data.

[Identification of Protein-Coding Gene Markers in Breast Invasive Carcinoma Based on Machine Learning].

SVM-T-RFE: a Novel Gene Selection Algorithm for Identifying Metastasis-Related Genes in Colorectal Cancer Using Gene Expression Profiles.

Identification of Triple-Negative Breast Cancer Genes and a Novel High-Risk Breast Cancer Prediction Model Development Based on PPI Data and Support Vector Machines.

Identification of Metastasis-Related Genes for Predicting Prostate Cancer Diagnosis, Metastasis and Immunotherapy Drug Candidates Using Machine Learning Approaches

Identifying network biomarkers based on protein-protein interactions and expression data

Integrating Protein Sequence and Expression Level to Analysis Molecular Characterization of Breast Cancer Subtypes

Identification of Differentially Expressed Genes Between Original Breast Cancer and Xenograft Using Machine Learning Algorithms

XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer

Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis

Towards key genes identification for breast cancer survival risk with neural network models

Protein-Protein Interaction Reveals Synergistic Discrimination of Cancer Phenotype

Identification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis

Metastasis-related Gene Identification by Compound Constrained NMF and a Semisupervised Cluster Approach Using Pancancer Multiomics Features.